Lawsuits Filed Against VRM, DDD and ACAD - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Vroom, Inc. (NASDAQ:VRM)
CONTACT JAKUBOWITZ ABOUT VRM:
https://claimyourloss.com/securities/vroom-inc-loss-submission-form/?id=15322&from=1
Class Period : June 9, 2020 - March 3, 2021
Lead Plaintiff Deadline : May 21, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
3D Systems Corporation (NYSE:DDD)
CONTACT JAKUBOWITZ ABOUT DDD:
https://claimyourloss.com/securities/3d-systems-corp-loss-submission-form/?id=15322&from=1
Class Period : May 6, 2020 - March 1, 2021
Lead Plaintiff Deadline : June 8, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, 3D Systems' public statements were materially false and/or misleading at all relevant times.
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)
CONTACT JAKUBOWITZ ABOUT ACAD:
https://claimyourloss.com/securities/acadia-pharmaceuticals-inc-loss-submission-form/?id=15322&from=1
Class Period : June 15, 2020 - April 4, 2021
Lead Plaintiff Deadline : June 18, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/643437/Lawsuits-Filed-Against-VRM-DDD-and-ACAD--Jakubowitz-Law-Pursues-Shareholders-Claims
